Become A Featured Company

The Crucial Role of Genetics in the Future of the Cannabis Industry

Robin Lefferts

November 6th, 2018

Exclusive, News, Top News

The history of the legal cannabis industry is fairly short, a work in progress. The legal market is only beginning to leave behind its black market origins, and the prohibition on scientific research around the plant is being lifted. One fact that has recently come to light is that a particular strain of cannabis can vary widely in its genetic makeup and active ingredient profile, depending on how it is grown, the source of the seed, and other variables. Consumers buying OG Kush or Pineapple Express are not, in any way, guaranteed the same product each time they buy their chosen strain. This can lead to an inconsistent experience for both medical patients and recreational consumers, and is certainly no way to market a product.

AREV Brands International (CSE: AREV) is a vertically integrated cannabis company that recognizes the need to constantly breed innovative strains that have distinct and proprietary  cannabinoid and terpene profiles. The company through its ownership of BC Bud Depot controls a seed bank of hundreds of rare strains, and is identifying a variety of desired genetic traits within its catalogue to replicate on a large scale. By protecting the intellectual property associated with its genetics, AREV is positioning itself as a foundational player in both the medical and adult-use legal cannabis markets. The strategy to breed innovative plants that encase the experience and flavor profiles into bud, oil, shatter and ingredients to be used in branded products is ideally what the consumer demands. AREV recognized this and built it right into its value proposition.

The Truth About Cannabis Variants

Most dispensary workers, or budtenders, will offer advice on the types of strains available and the expected effects of those strains. If you want to melt into the couch, this strong Indica should do the trick. Looking for a creative and energetic boost? Here is the perfect Sativa. However, recent research indicates that these characteristics are not necessarily consistent within strains, and even calls into question the generally accepted classifications of Indica, Sativa, and Hybrid varieties.

AREV’s Solution

As part of its integrator approach to the cannabis market, AREV recently purchased BC Bud Depot. BCBD is one of the world’s most respected and awarded breeders of cannabis, holding a seed bank of hundreds of unique strains and offering a vast international distribution network. BC Bud Depot’s strains have won awards at numerous international cannabis competitions over the last 15 years or so. The company utilizes its seed bank of rare and award winning strains and leverages its expertise in breeding, producing hundreds of thousands of highly-consistent seeds at a time.

AREV and BC Bud Depot are currently in the process of sequencing the genomes of a number of their best strains. The exercise has a variety of potential benefits. Identifying, cataloging, and preserving specific genetic profiles will support protecting the company’s intellectual property. Patent protection in the cannabis industry does not exist at this point, but it’s easy to see that there is a need for it as the industry matures in its newly legal framework. Much like the pharmaceutical drug development industry, the creators of specific genetic lines of cannabis will need to protect and profit from their creations. Genome sequencing allows for this, and consumers will also be assured that their preferred strain, as an exact genetic identity, delivers as advertised regardless of the point of purchase.

Genome sequencing can also greatly inform AREV’s breeding decisions going forward. By identifying and isolating specific genetic traits and desirable qualities, strains can be chosen for interbreeding with a higher degree of confidence in achieving the intended results. The breeding program is intended to be a revenue generator for the company by offering strain development to legal cultivators around the world and through the licensing of proprietary strains.

Matthew Harvey, founder of BC Bud Depot and the man responsible for its breeding program, stated, “We are excited to identify, catalog, and protect our superior genetics. With our best genomic profiles recorded, we will utilize tissue culture and cryogenic technology to preserve our varieties into the future. We have the most complete seed bank in the Canadian market and look forward to leveraging both our history and our dedication to using the latest technology to cement the crucial role of genetics in the development of the legal cannabis industry.”

Looking Ahead

AREV Brands International is developing along several lines at once. Through a joint venture with Alternative Extracts Inc., the company offers state-of-the-art extraction services and has developed a proprietary method for the infusion of oil-based extracts into beverages. The company is planning a wide variety of extract-based products like oils, creams and sprays that springboard off of the extraction technology.

AREV also has an extensive distribution network for its current health-related natural products that should make its go-to-market transition for cannabis products fairly seamless. At the base of all of its cannabis initiatives lies the company’s catalog of proprietary strains and proven breeding success, giving AREV a head start in a sector of the cannabis industry that will only become more influential as the industry gains legal traction throughout the world.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Robin Lefferts

Robin Lefferts has been involved in the legal cannabis industry since 2012, sometimes as an active participant and always as an interested observer.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading